Daily non-political popular news in brief.

Painkillers may threaten power of vaccines

With flu-shot season in full swing and widespread anticipation of the HPV vaccine to prevent cervical cancer, a new University of Rochester study suggests that using common painkillers around the time of vaccination might not be a good idea.

Read more »

Keywords: painkillers, threaten, power, vaccines, painkiller, vaccine

« Previous | Next »

Similar news on "Painkillers may threaten power of vaccines":

1. In-shell vaccine for chick disease
   01-04-2007 · EurekAlert!
   Infectious bronchitis virus causes devastating losses to the poultry industry but scientists are now developing a new way to vaccinate chicks against the disease -- one that can be delivered while they are still in their egg. Researchers have used a "reverse genetic" system to produce a new vaccine strain which is safe to deliver to chicks while they are still in the egg, making it more effective than current vaccines.
   Similar news · Read more »
   
2. From clinical cancer research: rethinking therapeutic cancer vaccine trials
   07-03-2007 · EurekAlert!
   Ongoing therapeutic cancer vaccine trials have yet to show evidence of vaccines spurring a patient's immune system to shrink tumors -- yet patients who receive these vaccines in trials tend to live longer and respond better to subsequent treatment. In the July 1 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, a team of National Cancer Institute researchers asks a fundamental question: are we looking at cancer vaccine trials the wrong way?
   Similar news · Read more »
   
3. New nanoparticle vaccine is more effective but less expensive
   09-16-2007 · EurekAlert!
   Good news for public health: Bioengineering researchers from the EPFL in Lausanne, Switzerland, have developed and patented a nanoparticle that can deliver vaccines more effectively, with fewer side effects, and at a fraction of the cost of current vaccine technologies.
   Similar news · Read more »
   
4. Babies excrete vaccine-mercury quicker than originally thought
   01-30-2008 · EurekAlert!
   February's issue of Pediatrics offers another reason to rethink blaming the spike in autism diagnoses on thimerosal, a mercury-containing preservative routinely used in several childhood vaccines until the late '90s. New research from the University of Rochester suggests that infants' bodies expel the thimerosal mercury much faster than originally thought -- thereby leaving little chance for a progressive building up of the toxic metal.
   Similar news · Read more »
   
5. Why don't painkillers work for people with fibromyalgia?
   09-27-2007 · EurekAlert!
   New research shows that people with fibromyalgia were found to have reduced binding ability of a type of receptor in the brain that is the target of opioid painkiller drugs such as morphine.
   Similar news · Read more »
   
6. Vaccine to cope with viral diversity in HIV
   04-26-2007 · EurekAlert!
   The ability of HIV-1 to develop high levels of genetic diversity and acquire mutations to escape immune pressures contributes to our difficulties in producing a vaccine. David Nickle et al present here an efficient algorithm to develop vaccines that cope with the diversity of HIV or other variable pathogens.
   Similar news · Read more »
   
7. Novel vaccine concept developed by scientists at the Wistar Institute
   01-31-2008 · EurekAlert!
   A new vaccine design strategy developed by scientists at the Wistar Institute could help to develop vaccines against diseases like AIDS and cervical cancer. The secret is using a herpes simplex protein called glycoprotein D to block a receptor molecule on antigen-presenting cells. Wistar scientists showed that vaccine vectors made by fusing glycoprotein D with genes from HIV and HPV antigens increase the immune system's response to those antigens in cell cultures and mice.
   Similar news · Read more »
   
8. "Combination" Lyme Disease Vaccine Proteins Patented
   04-09-2007 · Brookhaven National Laboratory
   Scientists at Brookhaven Lab and collaborators at Stony Brook University have received U.S. Patent Number 7,179,448 for developing chimeric, or "combination," proteins that may advance the development of vaccines and diagnostic tests for Lyme disease.
   Similar news · Read more »
   
9. Smallpox outbreak: How long would it take for vaccines to protect people? Would it work?
   04-30-2007 · EurekAlert!
   In the event of a smallpox outbreak in the United States, how long would it take for a vaccine to start protecting Americans by stimulating an immune response? A new national study led by Saint Louis University School of Medicine will attempt to answer this question.
   Similar news · Read more »
   
10. Virus used to create experimental HIV vaccines directly impairs the immune response
    11-15-2007 · EurekAlert!
    Leading efforts to create an HIV vaccine have hinged on the use of viruses as carriers for selected elements of the HIV virus. Recently, however, evidence has emerged that some of these so-called viral vector systems may undermine the immune system and should not be used for vaccine development. Now, a new study from scientists at the Wistar Institute provides strong support for the idea that some viral-vector vaccines may cause more harm than good.
    Similar news · Read more »